Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab.

Kurdi AT, Glavey SV, Bezman NA, Jhatakia A, Guerriero JL, Manier S, Moschetta M, Mishima Y, Roccaro A, Detappe A, Liu CJ, Sacco A, Huynh D, Tai YT, Robbins MD, Azzi J, Ghobrial IM.

Mol Cancer Ther. 2018 Jul;17(7):1454-1463. doi: 10.1158/1535-7163.MCT-17-0998. Epub 2018 Apr 13.

2.

Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brown LE, Gray N, Bradner J, Whitesell L, Porco JA Jr, Ghobrial IM.

Sci Transl Med. 2017 May 10;9(389). pii: eaal2668. doi: 10.1126/scitranslmed.aal2668.

3.

E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271.

Natoni A, Smith TAG, Keane N, McEllistrim C, Connolly C, Jha A, Andrulis M, Ellert E, Raab MS, Glavey SV, Kirkham-McCarthy L, Kumar SK, Locatelli-Hoops SC, Oliva I, Fogler WE, Magnani JL, O'Dwyer ME.

Leukemia. 2017 Dec;31(12):2642-2651. doi: 10.1038/leu.2017.123. Epub 2017 Apr 25.

4.

Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.

Glavey SV, Naba A, Manier S, Clauser K, Tahri S, Park J, Reagan MR, Moschetta M, Mishima Y, Gambella M, Rocci A, Sacco A, O'Dwyer ME, Asara JM, Palumbo A, Roccaro AM, Hynes RO, Ghobrial IM.

Leukemia. 2017 Nov;31(11):2426-2434. doi: 10.1038/leu.2017.102. Epub 2017 Mar 27.

PMID:
28344315
5.

Prognostic role of circulating exosomal miRNAs in multiple myeloma.

Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco A, Roccaro AM, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller E, Trippa L, Ghobrial IM.

Blood. 2017 Apr 27;129(17):2429-2436. doi: 10.1182/blood-2016-09-742296. Epub 2017 Feb 17.

6.

The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma.

Manier S, Powers JT, Sacco A, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta M, Shi J, Mishima Y, Roche-Lestienne C, Leleu X, Roccaro AM, Daley GQ, Ghobrial IM.

Leukemia. 2017 Apr;31(4):853-860. doi: 10.1038/leu.2016.296. Epub 2016 Oct 24.

7.

Epigenetics in Multiple Myeloma.

Glavey SV, Manier S, Sacco A, Salem K, Kawano Y, Bouyssou J, Ghobrial IM, Roccaro AM.

Cancer Treat Res. 2016;169:35-49. Review.

PMID:
27696257
8.

Genomic Aberrations in Multiple Myeloma.

Manier S, Salem K, Glavey SV, Roccaro AM, Ghobrial IM.

Cancer Treat Res. 2016;169:23-34. Review.

PMID:
27696256
9.

Monoclonal gammopathy: The good, the bad and the ugly.

Glavey SV, Leung N.

Blood Rev. 2016 May;30(3):223-31. doi: 10.1016/j.blre.2015.12.001. Epub 2015 Dec 17. Review.

PMID:
26732417
10.

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation.

Leung N, Kumar SK, Glavey SV, Dispenzieri A, Lacy MQ, Buadi FK, Hayman SR, Dingli D, Kapoor P, Zeldenrust SR, Russell SJ, Lust JA, Hogan WJ, Rajkumar SV, Gastineau DA, Kourelis TV, Lin Y, Gonsalves WI, Go RS, Gertz MA.

Nephrol Dial Transplant. 2016 Aug;31(8):1284-9. doi: 10.1093/ndt/gfv328. Epub 2015 Nov 30.

PMID:
26627634
11.

American Society of Hematology Annual Meeting 2014: highlights in multiple myeloma.

Glavey SV, Ghobrial IM.

Expert Rev Hematol. 2015 Jun;8(3):273-5. doi: 10.1586/17474086.2015.1029449. Epub 2015 Mar 24.

PMID:
25804827
12.

The cancer glycome: carbohydrates as mediators of metastasis.

Glavey SV, Huynh D, Reagan MR, Manier S, Moschetta M, Kawano Y, Roccaro AM, Ghobrial IM, Joshi L, O'Dwyer ME.

Blood Rev. 2015 Jul;29(4):269-79. doi: 10.1016/j.blre.2015.01.003. Epub 2015 Jan 23. Review.

PMID:
25636501
13.

Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.

Reagan MR, Mishima Y, Glavey SV, Zhang Y, Manier S, Lu ZN, Memarzadeh M, Zhang Y, Sacco A, Aljawai Y, Shi J, Tai YT, Ready JE, Kaplan DL, Roccaro AM, Ghobrial IM.

Blood. 2014 Nov 20;124(22):3250-9. doi: 10.1182/blood-2014-02-558007. Epub 2014 Sep 9.

14.

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.

Glavey SV, Manier S, Natoni A, Sacco A, Moschetta M, Reagan MR, Murillo LS, Sahin I, Wu P, Mishima Y, Zhang Y, Zhang W, Zhang Y, Morgan G, Joshi L, Roccaro AM, Ghobrial IM, O'Dwyer ME.

Blood. 2014 Sep 11;124(11):1765-76. doi: 10.1182/blood-2014-03-560862. Epub 2014 Jul 24.

15.

Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.

Sahin I, Azab F, Mishima Y, Moschetta M, Tsang B, Glavey SV, Manier S, Zhang Y, Sacco A, Roccaro AM, Azab AK, Ghobrial IM.

Am J Hematol. 2014 Nov;89(11):1030-6. doi: 10.1002/ajh.23814. Epub 2014 Aug 12.

16.

AKT as a therapeutic target in multiple myeloma.

Keane NA, Glavey SV, Krawczyk J, O'Dwyer M.

Expert Opin Ther Targets. 2014 Aug;18(8):897-915. doi: 10.1517/14728222.2014.924507. Epub 2014 Jun 6. Review.

PMID:
24905897
17.

Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination.

Sahin I, Moschetta M, Mishima Y, Glavey SV, Tsang B, Azab F, Manier S, Zhang Y, Maiso P, Sacco A, Azab AK, Roccaro AM, Ghobrial IM.

Blood Cancer J. 2014 Apr 25;4:e204. doi: 10.1038/bcj.2014.24. No abstract available.

18.

Posterior pharyngeal candidiasis in the absence of clinically overt oral involvement: a cross-sectional study.

Glavey SV, Keane N, Power M, O'Regan AW.

Lung. 2013 Dec;191(6):663-8. doi: 10.1007/s00408-013-9503-3. Epub 2013 Sep 13.

PMID:
24030864
19.

Long-term outcome of patients with multiple [corrected] myeloma-related advanced renal failure following auto-SCT.

Glavey SV, Gertz MA, Dispenzieri A, Kumar S, Buadi F, Lacy M, Hayman SR, Kapoor P, Dingli D, McCurdy A, Hogan WJ, Gastineau DA, Leung N.

Bone Marrow Transplant. 2013 Nov;48(12):1543-7. doi: 10.1038/bmt.2013.109. Epub 2013 Aug 5. Erratum in: Bone Marrow Transplant. 2014 Jul;49(7):996. Kapoor, P [added].

PMID:
23912663
20.

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

Leung N, Glavey SV, Kumar S, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Rajkumar SV, Gertz MA.

Haematologica. 2013 Jun;98(6):988-92. doi: 10.3324/haematol.2012.079210.

21.

Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis.

Irazabal MV, Eirin A, Gertz MA, Dispenzieri A, Kumar S, Buadi FK, Lacy MQ, Hayman SR, Dingli D, Hogan WJ, Gastineau DA, Glavey SV, Amer H, Leung N.

Am J Hematol. 2012 Jan;87(1):51-4. doi: 10.1002/ajh.22202. Epub 2011 Nov 11.

22.

Umbilical artery tone in maternal obesity.

Hehir MP, Moynihan AT, Glavey SV, Morrison JJ.

Reprod Biol Endocrinol. 2009 Jan 22;7:6. doi: 10.1186/1477-7827-7-6.

23.

Uterorelaxant effect of ghrelin on human myometrial contractility.

Hehir MP, Glavey SV, Morrison JJ.

Am J Obstet Gynecol. 2008 Mar;198(3):323.e1-5. doi: 10.1016/j.ajog.2007.09.040. Epub 2008 Feb 21.

PMID:
18177835
24.

Inhibitory effect of leptin on human uterine contractility in vitro.

Moynihan AT, Hehir MP, Glavey SV, Smith TJ, Morrison JJ.

Am J Obstet Gynecol. 2006 Aug;195(2):504-9. Epub 2006 May 2.

PMID:
16647683

Supplemental Content

Loading ...
Support Center